AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEURIZON THERAPEUTICS LTD

0.096

+0.0011.05%

Volume:111.80K

Turnover:10.88K

Market Cap:66.11M

PE:-2.82

High:0.098

Open:0.098

Low:0.096

Close:0.095

52wk High:0.185

52wk Low:0.079

Shares:688.63M

Float Shares:351.37M

Volume Ratio:0.27

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.034

EPS(LYR):-0.034

ROE:-254.33%

ROA:-136.74%

PB:23.44

PE(LYR):-2.82

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NEURIZON THERAPEUTICS LTD

Exchange:

ASX

Establishment Date:

2000

Employees:

4

Office Location:

Suite 2,Level 11,385 Bourke Street,Melbourne,Victoria,Australia

Website:

http://www.pharmaust.com

Zip Code:

3000

Phone:

Fax:

- -

Introduction:

PharmAust Limited operates as a drug discovery and development company in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers in humans and animals. Its lead candidate is Monepantel, which are in Phase II clinical trials for the treatment of cancer. The company also provides highly specialized medicinal and synthetic chemistry services on a contract basis to clients to the drug discovery and pharmaceutical industries. PharmAust Limited is based in Bentley, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NUZ.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NUZ.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NUZ.AU\",,,,,undefined,":{"symbol":"NUZ.AU","market":"AU","secType":"STK","nameCN":"NEURIZON THERAPEUTICS LTD","latestPrice":0.096,"timestamp":1771823520000,"preClose":0.095,"halted":0,"volume":111799,"delay":0,"changeRate":0.010526315789473693,"nameEN":"NEURIZON THERAPEUTICS LTD","floatShares":351374969,"shares":688628681,"eps":-0.034045,"marketStatus":"Not Yet Opened","change":0.001,"latestTime":"02-23 16:12:00 AEDT","open":0.098,"high":0.098,"low":0.096,"amount":10884,"amplitude":0.021053,"askPrice":0.098,"askSize":70353,"bidPrice":0.096,"bidSize":50158,"shortable":3,"etf":0,"ttmEps":-0.034045,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771887600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.095,"openAndCloseTimeList":[[1771801200000,1771822800000]],"volumeRatio":0.269461,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NUZ.AU\",,,,,undefined,":{"symbol":"NUZ.AU","floatShares":351374969,"roa":"-136.74%","roe":"-254.33%","lyrEps":-0.034045,"volumeRatio":0.269461,"shares":688628681,"dividePrice":0,"high":0.098,"amplitude":0.021053,"preClose":0.095,"low":0.096,"week52Low":0.079,"pbRate":"23.44","psRate":"42.99","week52High":0.185,"institutionHeld":0,"latestPrice":0.096,"committee":-0.167578,"eps":-0.034045,"divideRate":0,"volume":111799,"delay":0,"ttmEps":-0.034045,"open":0.098,"prevYearClose":0.085,"prevWeekClose":0.095,"prevMonthClose":0.09,"prevQuarterClose":0.085,"fiveDayClose":0.095,"twentyDayClose":0.097,"sixtyDayClose":0.11,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NUZ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NUZ.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6524046,"yearFounded":2000,"employeeNum":4,"address":"Suite 2,Level 11,385 Bourke Street,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9692 7222"},"stockCompanyDetail":{"websiteUrl":"http://www.pharmaust.com","stockEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":0.1585},{"period":"3month","weight":-0.0952},{"period":"6month","weight":-0.3871},{"period":"1year","weight":-0.3448},{"period":"ytd","weight":0.1176}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0113},{"period":"3month","weight":0.0666},{"period":"6month","weight":0.055},{"period":"1year","weight":0.2181},{"period":"ytd","weight":0.0215}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"PharmAust Limited operates as a drug discovery and development company in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers in humans and animals. Its lead candidate is Monepantel, which are in Phase II clinical trials for the treatment of cancer. The company also provides highly specialized medicinal and synthetic chemistry services on a contract basis to clients to the drug discovery and pharmaceutical industries. PharmAust Limited is based in Bentley, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.52,"avgChangeRate":0.046932},{"month":2,"riseRate":0.458333,"avgChangeRate":0.016214},{"month":3,"riseRate":0.291667,"avgChangeRate":-0.015294},{"month":4,"riseRate":0.291667,"avgChangeRate":-0.047436},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.042485},{"month":6,"riseRate":0.75,"avgChangeRate":0.171035},{"month":7,"riseRate":0.333333,"avgChangeRate":0.015875},{"month":8,"riseRate":0.291667,"avgChangeRate":-0.092038},{"month":9,"riseRate":0.5,"avgChangeRate":0.034086},{"month":10,"riseRate":0.28,"avgChangeRate":-0.030341},{"month":11,"riseRate":0.44,"avgChangeRate":-0.012166},{"month":12,"riseRate":0.56,"avgChangeRate":0.058214}],"exchange":"ASX","name":"NEURIZON THERAPEUTICS LTD","nameEN":"NEURIZON THERAPEUTICS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NUZ.AU\",market:\"AU\",,,undefined,":null}}